ConvaTec Provides Business Updates


LUXEMBOURG (27 June 2016) — ConvaTec is pleased to announce the appointment of Erik Zimmer as global head of ConvaTec’s Ostomy Care franchise. Erik joins from Sebia, where he was Chief Operating Officer. ConvaTec is also pleased to announce the appointment of Oliver Greaves to support the company’s corporate development work and key strategic projects.

ConvaTec is in the early stages of considering options for potentially raising equity, including in the public markets, and it is expected that Oliver will also support this process.

About ConvaTec

ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. We are owned by Nordic Capital and Avista Capital Partners. More information is available at

Notes to Editors

Erik Zimmer was formerly the Chief Operating Officer of Sebia. Prior to that, Erik had roles at BioMérieux, ConvaTec and Abbott Laboratories.

Oliver Greaves was formerly the CEO of Lower Belford Resources and at Bank of America Merrill Lynch prior to that.

# # #

There can be no certainty that any possible equity raise contemplated in this announcement will proceed nor as to the terms on which any possible transaction might be concluded. This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, subscribe for, sell or otherwise dispose of, any securities whether pursuant to this announcement or otherwise.
No person has been authorised to give any information or to make any representations other than those contained in this announcement.
The issue of this announcement shall not in any circumstances create any implication that ConvaTec shall be required to provide further updates on the status of any matters contemplated in this announcement (save as may be required by law or regulation).